205 related articles for article (PubMed ID: 12407835)
1. [Refractory heart failure. Positive inotropes and beta blockers: alternative or complementary treatments?].
Sabbadini G; Ciaccheri M; Castelli G; Sinagra G; Di Lenarda A
Ital Heart J Suppl; 2002 Aug; 3(8):804-11. PubMed ID: 12407835
[TBL] [Abstract][Full Text] [Related]
2. Inotropic therapy for heart failure: an evidence-based approach.
Felker GM; O'Connor CM
Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
[TBL] [Abstract][Full Text] [Related]
3. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
[TBL] [Abstract][Full Text] [Related]
5. [Positive inotropic agents].
Asanoi H
Nihon Rinsho; 2003 May; 61(5):827-32. PubMed ID: 12755010
[TBL] [Abstract][Full Text] [Related]
6. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
Erdmann E; Schwinger R; Böhm M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
[TBL] [Abstract][Full Text] [Related]
7. Inotropes in the management of acute heart failure.
Petersen JW; Felker GM
Crit Care Med; 2008 Jan; 36(1 Suppl):S106-11. PubMed ID: 18158469
[TBL] [Abstract][Full Text] [Related]
8. Nonglycoside inotropes in congestive heart failure. Are they beneficial or harmful?
Chatterjee K; Wolfe CL; DeMarco T
Cardiol Clin; 1994 Feb; 12(1):63-72. PubMed ID: 8181026
[TBL] [Abstract][Full Text] [Related]
9. Use of combination therapy with a beta-blocker and milrinone in patients with advanced heart failure.
Jennings DL; Thompson ML
Ann Pharmacother; 2009 Nov; 43(11):1872-6. PubMed ID: 19789358
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic blocking drugs in severe heart failure.
Fowler M
Rev Cardiovasc Med; 2002; 3 Suppl 3():S20-6. PubMed ID: 12447158
[TBL] [Abstract][Full Text] [Related]
11. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
[No Abstract] [Full Text] [Related]
12. [Beta-blockers and new drugs for cardiac failure].
Lechat P
Rev Prat; 1997 Dec; 47(19):2131-4. PubMed ID: 9501605
[TBL] [Abstract][Full Text] [Related]
13. Acute decompensated heart failure: best evidence and current practice.
Mehta R; Feldman D
Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
[TBL] [Abstract][Full Text] [Related]
14. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
Dulin BR; Krum H
Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
[TBL] [Abstract][Full Text] [Related]
15. [Treatment with beta blockers in advanced heart failure].
Gronda E; Bologna A; Mangiavacchi M; Andreuzzi B
Ital Heart J Suppl; 2000 Aug; 1(8):1011-8. PubMed ID: 10993007
[TBL] [Abstract][Full Text] [Related]
16. A novel approach to the development of positive inotropic agents for chronic heart failure.
Packer M
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S52-6. PubMed ID: 8907131
[TBL] [Abstract][Full Text] [Related]
17. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
18. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
Shakar SF; Abraham WT; Gilbert EM; Robertson AD; Lowes BD; Zisman LS; Ferguson DA; Bristow MR
J Am Coll Cardiol; 1998 May; 31(6):1336-40. PubMed ID: 9581729
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic management of heart failure: positive inotropic agents.
Cross JA
Crit Care Nurs Clin North Am; 1993 Dec; 5(4):589-97. PubMed ID: 8297549
[TBL] [Abstract][Full Text] [Related]
20. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A
G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
